Early Patient Engagement in Drug Development: Guiding Principles for Meaningful Collaboration

Despite broad recognition of the value of patient, care partner, and advocacy input in research, engagement often occurs late or without a clear connection to early scientific and development decisions. This white paper reflects a collaborative effort between BMS teams and patient advocacy leaders, who co-authored the work, to define what early engagement looks like in practice and how it can be applied in routine development.